Cryosite Ltd

CTE

Company Profile

  • Business description

    Cryosite Ltd provides an integrated clinical trial logistics service, biological storage and sample management service, including the storage of cord blood stem cells for private use. It supports a diverse portfolio of materials, including Good Manufacturing Practice (GMP) clinical trial products, Australian Register of Therapeutic Goods (ARTG) approved medicines, biologics, Research and Development materials, and medical devices, among others. The group's operating segments are: Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord blood. The majority of its revenue is generated from the Ambient, cold, and frozen segment, which provides storage and distribution of small-molecule drugs and related products requiring ambient, refrigerated, or frozen conditions.

  • Contact

    13a Ferndell Street
    South Granville
    SydneyNSW2142
    AUS

    T: +61 288652000

    https://www.cryosite.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    30 June 2027

    Employees

    25

Stocks News & Analysis

stocks

Wide moat ASX share beats earnings guidance

Wide moat share continues to grow despite a challenging residential construction market.
stocks

Cheap with attractive yield: Fair Value lifted for retail REIT after earnings

Management expects both earnings and distributions to increase next year.
stocks

Cheap ASX share may have more room to run

Shares are cheap despite rebounding share price, yet risks remain.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,443.7017.900.19%
CAC 408,711.5114.52-0.17%
DAX 4026,309.4014.48-0.06%
Dow JONES (US)53,975.9860.95-0.11%
FTSE 10010,869.306.800.06%
HKSE25,652.82284.67-1.10%
NASDAQ26,605.3685.26-0.32%
Nikkei 22566,970.221,363.512.08%
NZX 50 Index13,860.6627.58-0.20%
S&P 5007,753.114.53-0.06%
S&P/ASX 2009,250.6013.800.15%
SSE Composite Index3,934.0932.50-0.82%

Market Movers